HEPI40223
Dermatomycosis
is topic is not usually covered in sites about epidemiology, the disease affects millions of peoples in USA and
it can be an infection control issue. We have included the following page to answer questions from readers.
Treatment
Choices for Dermatomycosis
|
Dermatophytes |
TYPE OF ADMINIST/OBSERV |
POSOLOGY |
|
FINGERS |
Fingernails
PO |
Terbinafine
125 –250 q12 po x 11/2 Mo
Or
Itraconazole 200 q12 x po 11/2 Mo
|
|
|
Fingernails
Topical |
1.
nail solution containing 28% tioconazole,
2.
40% urea and bifonazole
3.
5% amorolfine used as a nail lacquer
|
|
|
|
|
|
TOE |
Toenails
PO |
Terbinafine
125-250 q12 po x 3 Mo
Or
Itraconazole 200 q24 po x 3 Mo
|
|
|
T.
pedis Topical |
Terbinafine
topical q12 x po 11/2 Mo
|
|
|
|
|
|
SCALP |
T.
capitis PO ( scrap Culture) |
Griseofulvin
600-1200 mg/kg po q24 X 3 Mo
|
|
|
|
|
|
BODY |
T.
cruris, corporis |
Terbinafine
125-250 q12 po x 11/2 Mo |
|
|
|
|
References: Hay, R. Dermatophytosis and other superficial mycoses.
Mandel, Bennett, Dolin. Principles and Practice of Infectious Diseases.
Notice: Information of this site does not intent to replace therapy provided Medical Professionals and
are not guidelines. Particular medical conditions, such as renal or hepatic impairment, childhood and pregnancy may require
different posology.
Disclaimer: The material edited in this website is intended for information purposes only. Please refer
to the references provided for updated information regarding to the topic.
